Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7014
Rank
NZ$0.89 B
Marketcap
NZ$44.92
Share price
-2.60%
Change (1 day)
-23.17%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement